Grant RDF
pages:- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- more...
- A Randomized, 4-Treatment, 5-Period Pilot Dose Response Study of Inhaled Salmeterol Xinafoate in Fluticasone.....
- A Randomized, Active-Controlled, Dose-Ranging Estimation Study to Evaluate the Safety, Tolerability, and Efficacy . .
- A Randomized, Bouble-Blind, Multi-Cnter Phase III Study of Brivanib Plus Best Supportive Care (Bsc) Versus Placebo Plus
- A Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the Zomaxx Drug Eluting Coronary Stent System...
- A Randomized, Controlled, Open-Label, Multicenter, Phase II Study of the Safety and Efficacy of Sunitinib in Comb.......
- A Randomized, Ctrl, O/L Trial of Degarelix Intermittent Therapy Vs Continuous Androgen Deprivation Therapy........
- A Randomized, D-Blind, Placebo-Ctrl, Study of the Safety & Tolerability of E5555 and Its Effects on Markers or Intra...
- A Randomized, D/B, Placebo-Controlled Study to Assess the Efficacy & Safety of Cinacalcet Hcl in Pediatric Subjects...
- A Randomized, Dbl-Bl, Placebo-Contrld, Parallel-Group Study of the Efficacy and Safety of the Acat Inhibitor Cs-505 For
- A Randomized, Dluble-Blind, Vehicle-Controlled, Parallel Armstudy of 552-02 in Subjects With Dry Mouth Associated With S
- A Randomized, Double Blind Muti-Center Study Comparing the Effects of Cardvedilol Modified Release.....
- A Randomized, Double Blind Study of Safety of Zd6474 in Combin with Taxotere in Subjects with Non-Small Cell Lung ..
- A Randomized, Double Blind, Double-Dummy, 2-Period Crossoverstudy to Characterize the Pk/Pd Relationship of a 20-Minute
- A Randomized, Double Blind, Multicenter, Study Evaluating the Effects of Eplerenone Versus Placebo on Ventricular.......
- A Randomized, Double Blind, Placebo Controlled Study of Sd-809 Extended Release for the Treatment of Chorea....
- A Randomized, Double Blind, Placebo Controlled, Crossover Safety Study of 2 Single Repeat Doses of Map
- A Randomized, Double Blind, Placebo-Controlled, Ascending Si Ngle Dose Study of the Safety and Pharmacokinetics
- A Randomized, Double Blind, Placebo-Controlled, Multicenter Phase III Study of Regorafenib in Patients W/ Hepatocellular
- A randomized, double blind, placebo-controlled, multicenter phase III study of regorafenib in patients with hepatocellular carcinoma (HCC) after sorafenib
- A Randomized, Double Masked, Active Controlled Phase III Study of the Efficacy....
- A Randomized, Double-Blin, Placebo Controlled, Parallel- Group Study to Evaluate the Effect of Sar236553/Regn727
- A Randomized, Double-Blind Comparison of Ly686017, Paroxetine, and Placebo in the Treatment of Social Anxiety Disorder
- A Randomized, Double-Blind Double-Dummy, Efficacy, Safety and Tolerability Study of Levodop-Carbidopa Intestinal.....
- A Randomized, Double-blind Placebo Controlled Parallel Group, Multinational Trial.....
- A Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics
- A Randomized, Double-Blind Study to Assess the Safety and Efficacy of Different Dose Levels of Pasireotide (Som230)S.C
- A Randomized, Double-Blind, 4-Treatment, 5-Period Pilot Doseresponse Study of Inhaled Fluticasone Propionate (Fp)....
- A Randomized, Double-Blind, Double-Dummy, Multi-Center Studyto Assess Safety and Effecacy of Bay 94-8862 in Subjects
- A Randomized, Double-Blind, Double-Dummy...Levodopa-Carbidopa Intestinal Ge..Persistent Motor Fluctuations.
- A Randomized, Double-Blind, Multicenter Study Comparing Mdx 010 Monotherapy, Mdx 010 in Combination With a Melanoma Pept